Who is eligible to apply for KILITCH DRUGS rights issue?

Existing shareholders of KILITCH DRUGS as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.

How can existing shareholders apply for KILITCH DRUGS rights issue?

Shareholders can apply for KILITCH DRUGS rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.

Is the rights issue of KILITCH DRUGS mandatory for existing shareholders?

No! Participation in KILITCH DRUGS rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.

Has KILITCH DRUGS announced any rights issues in the past?

Yes, KILITCH DRUGS had its last rights issues on the record date: 15-07-2025. The rights ratio for this date was 2:23

What was the last rights issue price and ratio for KILITCH DRUGS?

The last rights issue for KILITCH DRUGS was on record date: 15-07-2025. The issue price was 357.00 and rights ratio was 2:23

Kilitch Drugs India Ltd Rights Issue

Kilitch Drugs India Ltd has announced 1 rights issues since 29 Aug, 2023, with the most recent issue declared on Jul 02, 2025 in the ratio of 2:23 at a price of ₹10 per share.

₹201.50₹201.50-4.22 (-2.05%)

Last updated on 04 Nov, 2026 | 00:42 IST

Dividends
Splits
Bonus
Rights

Kilitch Drugs India Rights Issue Details

Rights Ratio
2:23	10	347.00	15-07-2025	15-07-2025	02-07-2025

*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.